1
|
Cieśla M, Darmochwal-Kolarz DA, Kwaśniak K, Pałka A, Kolarz B. Plasma Circular-RNA 0005567 as a Potential Marker of Disease Activity in Rheumatoid Arthritis. Int J Mol Sci 2023; 25:417. [PMID: 38203588 PMCID: PMC10779327 DOI: 10.3390/ijms25010417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2023] [Revised: 12/22/2023] [Accepted: 12/26/2023] [Indexed: 01/12/2024] Open
Abstract
Circular RNAs (circRNAs) are noncoding molecules and are generated through back splicing, during which the 5' and 3' ends are covalently joined. Consequently, the lack of free ends makes them stable and resistant to exonucleases, and they become more suitable biomarkers than other noncoding RNAs. The aim of the study was to find an association between selected circRNAs and disease activity in patients with RA. A total of 71 subjects, 45 patients with RA and 26 healthy controls (HCs), were enrolled. In the RA group, 24 patients had high disease activity (DAS-28-ESR > 5.1) and 21 individuals were in remission (DAS-28-ESR ≤ 2.6). The cell line SW982 was used to evaluate the biological function of circ_0005567. The concentration of circ_0005567 in RA patients was elevated compared to HCs (median, 177.5 [lower-upper quartile, 83.13-234.6] vs. 97.83 [42.03-145.4], p = 0.017). Patients with high disease activity had a higher concentration of circ_0005567 than the control group (185.4 [112.72-249.25] vs. 97.83 [42.03-145.4], p = 0.015). In the cell line model, we found an association between circ_0005567 and miR-194-5p concentration and increased expression of mRNAs that may be related to cell proliferation. The plasma concentration of circ_0005567 may be a new potential biomarker associated with disease activity in patients with RA.
Collapse
Affiliation(s)
- Marek Cieśla
- Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, 35-959 Rzeszow, Poland; (D.A.D.-K.); (B.K.)
| | - Dorota A. Darmochwal-Kolarz
- Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, 35-959 Rzeszow, Poland; (D.A.D.-K.); (B.K.)
| | - Konrad Kwaśniak
- Centre for Innovative Research in Medical and Natural Sciences, Medical College of Rzeszów University, 35-310 Rzeszow, Poland
| | - Anna Pałka
- Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, 35-959 Rzeszow, Poland; (D.A.D.-K.); (B.K.)
| | - Bogdan Kolarz
- Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, 35-959 Rzeszow, Poland; (D.A.D.-K.); (B.K.)
| |
Collapse
|
2
|
Iwanski M, Kwaśniak K, Olszewska J, Głowacka A, Wróbel K, Wołowiec S, Tabarkiewicz J. 106P Knockout of lncRNA-CCAT1 with the use of CRISPR-Cas9 system and G7 PAMAM dendrimers influences apoptosis and proliferations of NSCLC cells. ESMO Open 2023. [DOI: 10.1016/j.esmoop.2023.100964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
3
|
Malysheva K, Kwaśniak K, Gnilitskyi I, Barylyak A, Zinchenko V, Fahmi A, Korchynskyi O, Bobitski Y. Functionalization of Polycaprolactone Electrospun Osteoplastic Scaffolds with Fluorapatite and Hydroxyapatite Nanoparticles: Biocompatibility Comparison of Human Versus Mouse Mesenchymal Stem Cells. Materials (Basel) 2021; 14:1333. [PMID: 33802003 PMCID: PMC8001513 DOI: 10.3390/ma14061333] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/31/2021] [Revised: 03/02/2021] [Accepted: 03/04/2021] [Indexed: 12/11/2022]
Abstract
A capability for effective tissue reparation is a living requirement for all multicellular organisms. Bone exits as a precisely orchestrated balance of bioactivities of bone forming osteoblasts and bone resorbing osteoclasts. The main feature of osteoblasts is their capability to produce massive extracellular matrix enriched with calcium phosphate minerals. Hydroxyapatite and its composites represent the most common form of bone mineral providing mechanical strength and significant osteoinductive properties. Herein, hydroxyapatite and fluorapatite functionalized composite scaffolds based on electrospun polycaprolactone have been successfully fabricated. Physicochemical properties, biocompatibility and osteoinductivity of generated matrices have been validated. Both the hydroxyapatite and fluorapatite containing polycaprolactone composite scaffolds demonstrated good biocompatibility towards mesenchymal stem cells. Moreover, the presence of both hydroxyapatite and fluorapatite nanoparticles increased scaffolds' wettability. Furthermore, incorporation of fluorapatite nanoparticles enhanced the ability of the composite scaffolds to interact and support the mesenchymal stem cells attachment to their surfaces as compared to hydroxyapatite enriched composite scaffolds. The study of osteoinductive properties showed the capacity of fluorapatite and hydroxyapatite containing composite scaffolds to potentiate the stimulation of early stages of mesenchymal stem cells' osteoblast differentiation. Therefore, polycaprolactone based composite scaffolds functionalized with fluorapatite nanoparticles generates a promising platform for future bone tissue engineering applications.
Collapse
Affiliation(s)
- Khrystyna Malysheva
- Department of Human Immunology, Faculty of Medicine, University of Rzeszow, Warzywna 1A, 35-959 Rzeszow, Poland; (K.M.); (K.K.)
- Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, Warzywna 1A, 35-959 Rzeszow, Poland
| | - Konrad Kwaśniak
- Department of Human Immunology, Faculty of Medicine, University of Rzeszow, Warzywna 1A, 35-959 Rzeszow, Poland; (K.M.); (K.K.)
- Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, Warzywna 1A, 35-959 Rzeszow, Poland
| | - Iaroslav Gnilitskyi
- “NoviNano Lab” LLC, Pasternaka 5, 79015 Lviv, Ukraine;
- Department of Photonics, Lviv Polytechnic National University, S. Bandera 12, 79013 Lviv, Ukraine;
| | - Adriana Barylyak
- Department of Therapeutic Dentistry, Danylo Halytsky Lviv National Medical University, Pekarska 69b, 79010 Lviv, Ukraine;
| | - Viktor Zinchenko
- Department of Chemistry of Functional Inorganic Materials, Bogatsky Physico-Chemical Institute of the National Academy of Sciences of Ukraine, Lustdorfska doroga 86, 65080 Odessa, Ukraine;
| | - Amir Fahmi
- Faculty of Technology and Bionics, Rhine-Waal University of Applied Science, Marie-Curie 1, 47533 Kleve, Germany;
| | - Olexandr Korchynskyi
- Department of Human Immunology, Faculty of Medicine, University of Rzeszow, Warzywna 1A, 35-959 Rzeszow, Poland; (K.M.); (K.K.)
- Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, Warzywna 1A, 35-959 Rzeszow, Poland
- Department of Biotechnology and Radiology, S.Gzhytskyi National University of Veterinary Medicine and Biotechnologies, 79010 Lviv, Ukraine
- Department of Molecular Immunology, Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 01161 Kyiv, Ukraine
| | - Yaroslav Bobitski
- Department of Photonics, Lviv Polytechnic National University, S. Bandera 12, 79013 Lviv, Ukraine;
- Institute of Physics, Centrum of Microelectronics and Nanotechnology, University of Rzeszow, S. Pigonia 1, 35-959 Rzeszow, Poland
| |
Collapse
|
4
|
Czarnik-Kwaśniak J, Kwaśniak K, Tutaj K, Filiks I, Uram Ł, Stompor M, Wołowiec S. Glucoheptoamidated polyamidoamine PAMAM G3 dendrimer as a vehicle for succinate linked doxorubicin; enhanced toxicity of DOX against grade IV glioblastoma U-118 MG cells. J Drug Deliv Sci Technol 2020. [DOI: 10.1016/j.jddst.2019.101424] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
5
|
Czarnik-Kwaśniak J, Kwaśniak K, Kwasek P, Świerzowska E, Strojewska A, Tabarkiewicz J. The Influence of Lycopene, [6]-Gingerol, and Silymarin on the Apoptosis on U-118MG Glioblastoma Cells In Vitro Model. Nutrients 2019; 12:E96. [PMID: 31905849 PMCID: PMC7019537 DOI: 10.3390/nu12010096] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2019] [Accepted: 12/22/2019] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Lycopene, gingerol, and silymarin have a potential anticancer activity in many types of neoplasms. Healthy lifestyle and proper diet are associated with a reduced risk of cancer and other diseases. Increasingly, clinical research focuses on the mechanisms of action of natural compounds and their impact on the development of cancer. The aim of the present study was to determine the effect of lycopene, gingerol, and silymarin on apoptosis, mitochondrial potential and caspase-3/7 activity in the U118-MG cell line. METHODS Human glioblastoma cells were incubated with lycopene, [6]-gingerol, and silymarin for 24 and 48 h. Apoptosis was monitored using the Annexin V labelling, caspase-3/7 activity, and early hallmark of apoptosis were determined with mitochondrial membrane potential changes. RESULTS Our data showed a significant decrease in the viability glioblastoma cells U118-MG after 48 h treatment with lycopene, [6]-gingerol, and silymarin. CONCLUSIONS Our data could confirm the stimulative effects of used compounds on apoptosis and changes in mitochondrial potential in a dose-dependent manner.
Collapse
Affiliation(s)
- Justyna Czarnik-Kwaśniak
- Centre for Innovative Research in Medical and Natural Sciences, Medical Faculty of University of Rzeszow, 1a Warzywna St., 35-310 Rzeszow, Poland;
- Department of Human Immunology, Medical Faculty of University of Rzeszow, 1a Warzywna St., 35-310 Rzeszow, Poland; (K.K.); (P.K.); (E.Ś.); (A.S.)
| | - Konrad Kwaśniak
- Department of Human Immunology, Medical Faculty of University of Rzeszow, 1a Warzywna St., 35-310 Rzeszow, Poland; (K.K.); (P.K.); (E.Ś.); (A.S.)
| | - Paulina Kwasek
- Department of Human Immunology, Medical Faculty of University of Rzeszow, 1a Warzywna St., 35-310 Rzeszow, Poland; (K.K.); (P.K.); (E.Ś.); (A.S.)
| | - Elżbieta Świerzowska
- Department of Human Immunology, Medical Faculty of University of Rzeszow, 1a Warzywna St., 35-310 Rzeszow, Poland; (K.K.); (P.K.); (E.Ś.); (A.S.)
| | - Agata Strojewska
- Department of Human Immunology, Medical Faculty of University of Rzeszow, 1a Warzywna St., 35-310 Rzeszow, Poland; (K.K.); (P.K.); (E.Ś.); (A.S.)
| | - Jacek Tabarkiewicz
- Centre for Innovative Research in Medical and Natural Sciences, Medical Faculty of University of Rzeszow, 1a Warzywna St., 35-310 Rzeszow, Poland;
- Department of Human Immunology, Medical Faculty of University of Rzeszow, 1a Warzywna St., 35-310 Rzeszow, Poland; (K.K.); (P.K.); (E.Ś.); (A.S.)
| |
Collapse
|